• SENSEX 80,918.78
    -266.80 (--0.33%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Mankind Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 38451.0
  • ISIN : INE634S01028
2,566.30 -1 (-0.04%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    2,558.90

  • Today’s High

    2,652.70

  • Open

    2,569.70

  • Perv Close

    2,567.20

  • 52W Low

    1,901.05

  • 52W High

    3,054.80

Key Indicators

  • P/E(TTM)

    58.43

  • Mar.Cap (₹Cr.)

    105,918.58

  • Div & Yield %

    0.00

  • Book Value(₹)

    354.72

  • Debt-Equity Ratio

    -0.04

  • AGM Date

    01-Aug-2025

  • EPS

    43.85

  • P/E Ratio

    58.43

Financials Ratios

  • Debt-Equity Ratio

    0.02

  • Mar.Cap (₹Cr.)

    105,918.58

  • RONW (%)

    23.12

  • ROCE (%)

    27.89

Score Board

  • Equity (₹ in Cr.)

    41.27

  • BV (₹)

    354.70

  • Sales( ₹ in Cr.)

    9,497.80

  • NP (in Cr.)

    1,691.18

  • NP Var(%)

    -4.0

  • Div%

    0.0

  • CPS (₹)

    50.10

  • EPS (₹)

    41.00

  • Traded Value (₹ in Lakhs)

    105,753.49

  • 52 Week High

    3,054.80

  • 52 Week Low

    1,901.05

  • Price BSE

    2562.0

  • Price NSE

    2,566.00

  • Market Capital( in Cr.)

    105,753.49

  • P/C Ratio

    51.10

  • P/E Ratio

    62.50

  • Price Vs.BV

    41.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 9,497.80 8,629.25 8,127.15 7,486.22 5,523.18 4,794.41
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 9,497.80 8,629.25 8,127.15 7,486.22 5,523.18 4,794.41
Other Income 554.44 374.03 162.78 203.81 154.50 93.85
Stock Adjustments 13.50 48.20 -267.89 365.27 254.25 44.51
Total Income 10,065.74 9,051.48 8,022.04 8,055.30 5,931.93 4,932.77
EXPENDITURE :            
Raw Materials 2,610.39 2,618.31 2,576.87 2,886.71 2,036.42 1,617.42
Power and Fuel Cost 88.97 80.91 62.00 60.36 47.16 46.49
Employee Cost 2,131.67 1,921.09 1,701.38 1,462.76 1,167.42 991.47
Other Manufacturing Expenses 203.70 145.78 113.62 93.57 56.71 57.73
Selling and Administration Expenses 1,770.41 1,518.78 1,539.07 1,378.52 905.53 696.80
Miscellaneous Expenses 143.09 125.69 168.47 131.08 192.07 185.06
Employee Benefit Expenses 2,131.67 1,921.09 1,701.38 1,462.76 1,167.42 991.47
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 6,948.23 6,410.56 6,161.40 6,013.00 4,405.31 3,594.98
Operating Profit 3,117.51 2,640.92 1,860.65 2,042.30 1,526.62 1,337.79
Interest 372.28 16.93 28.23 47.54 8.23 11.10
Gross Profit 2,745.23 2,623.99 1,832.42 1,994.76 1,518.39 1,326.69
Depreciation 378.01 335.26 269.58 123.33 78.19 61.77
Profit Before Tax 2,367.22 2,288.73 1,562.84 1,871.43 1,440.20 1,264.92
Current Tax 469.93 411.33 291.64 429.03 346.99 341.81
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -48.19 1.24 22.94 52.98 8.84 -35.11
Reported Net Profit 1,945.48 1,876.16 1,248.26 1,389.42 1,084.37 958.23
Extraordinary Items 254.30 105.89 29.02 62.07 30.09 18.58
Adjusted Net Profit 1,691.18 1,770.27 1,219.24 1,327.35 1,054.28 939.65
Adjustment below Net Profit 4.98 -6.66 -4.86 -0.79 -1.56 -69.15
P & L Balance brought forward 9,763.97 7,894.47 6,624.90 5,236.27 3,747.13 3,160.50
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 302.44
P & L Balance carried down 11,714.43 9,763.97 7,868.30 6,624.90 4,829.95 3,747.13
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 755.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 7.55
Earnings Per Share-Unit Curr 47.15 46.83 31.16 34.68 27.07 23.92
Earnings Per Share(Adj)-Unit Curr 47.15 46.83 - - - -
Book Value 354.83 242.21 194.31 163.27 118.18 91.15
Book Value(Adj)-Unit Curr 354.83 242.21 - - - -

Shareholding Pattern

  • Promoter Group

    72.68%

  • Public Share Holding

    27.32%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 74,921,805 18.15 74,921,805 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 225,038,807 54.52 225,038,807 3
Others 0 0.00 0 0
Sub Total 299,960,612 72.68 299,960,612 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 5,673 0.00 5,673 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 53,951,777 13.07 53,951,777 569
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 9,247,983 2.24 9,247,983 10
Mutual Funds / UTI 30,314,026 7.34 30,314,026 31
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,913,315 1.92 7,913,315 37
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 101,432,774 24.58 101,432,774 648
2] Non Institution
Bodies Corporate 4,413,328 1.07 4,413,328 673
Clearing Members 190 0.00 190 4
Directors of their Relatives 0 0.00 0 0
Employees 158,028 0.04 158,028 11
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 249,719 0.06 249,719 2,781
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 232,303 0.06 232,303 3,536
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 200,831 0.05 200,831 1
Individuals holding nominal share capital up to Rs. 1 lakh 6,059,837 1.47 6,059,837 171,874
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 4,657 0.00 4,657 7
Others 16,469 0.00 16,469 1
Sub Total 11,335,362 2.75 11,335,362 178,888
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 412,728,748 100.00 412,728,748 179,549

Company Background

Mankind Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Mankind Pharma Ltd
  • BSE Code : 38451.0
  • ISIN : INE634S01028

  • Incorporation Year

    1991

  • Registered Office

    208 Okhla Industrial Estate
    Phase-III, New Delhi,
    New Delhi-110020

  • Telephone

    91-11-47476600

  • FAX

  • Chairman

    RAMESH CHAND JUNEJA

  • Managing Director

    RAJEEV JUNEJA

  • Company Secretary

    Hitesh Kumar Jain

  • Auditor

    S R Batliboi & Co LLP/Bhagi Bhardwaj Gaur & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Mankind Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Mankind Pharma 2,562.30 9,991.01 9,497.80 57.42 14.88
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10